Gene Review:
HDGF - hepatoma-derived growth factor
Homo sapiens
Synonyms:
HMG-1L2, HMG1L2, Hepatoma-derived growth factor, High mobility group protein 1-like 2
- Hepatoma-derived growth factor is involved in lung remodeling by stimulating epithelial growth. Mori, M., Morishita, H., Nakamura, H., Matsuoka, H., Yoshida, K., Kishima, Y., Zhou, Z., Kida, H., Funakoshi, T., Goya, S., Yoshida, M., Kumagai, T., Tachibana, I., Yamamoto, Y., Kawase, I., Hayashi, S. Am. J. Respir. Cell Mol. Biol. (2004)
- Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Iwasaki, T., Nakagawa, K., Nakamura, H., Takada, Y., Matsui, K., Kawahara, K. Oncol. Rep. (2005)
- Functional proteomic analysis of melanoma progression. Bernard, K., Litman, E., Fitzpatrick, J.L., Shellman, Y.G., Argast, G., Polvinen, K., Everett, A.D., Fukasawa, K., Norris, D.A., Ahn, N.G., Resing, K.A. Cancer Res. (2003)
- Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Uyama, H., Tomita, Y., Nakamura, H., Nakamori, S., Zhang, B., Hoshida, Y., Enomoto, H., Okuda, Y., Sakon, M., Aozasa, K., Kawase, I., Hayashi, N., Monden, M. Clin. Cancer Res. (2006)
- Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. Everett, A.D., Lobe, D.R., Matsumura, M.E., Nakamura, H., McNamara, C.A. J. Clin. Invest. (2000)
- Protein kinase C activators suppress stimulation of capillary endothelial cell growth by angiogenic endothelial mitogens. Doctrow, S.R., Folkman, J. J. Cell Biol. (1987)
- Expression of hepatoma-derived growth factor in hepatocarcinogenesis. Yoshida, K., Nakamura, H., Okuda, Y., Enomoto, H., Kishima, Y., Uyama, H., Ito, H., Hirasawa, T., Inagaki, S., Kawase, I. J. Gastroenterol. Hepatol. (2003)
- Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors. Nowak, R.A. Environ. Health Perspect. (2000)
- Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. Everett, A.D., Narron, J.V., Stoops, T., Nakamura, H., Tucker, A. Am. J. Physiol. Lung Cell Mol. Physiol. (2004)
- Hepatoma derived growth factor is a nuclear targeted mitogen. Everett, A.D., Bushweller, J. Current drug targets. (2003)
- Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Zhang, J., Ren, H., Yuan, P., Lang, W., Zhang, L., Mao, L. Cancer Res. (2006)
- Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Shen, X.Y., Zacal, N., Singh, G., Rainbow, A.J. Photochem. Photobiol. (2005)
- Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Okuda, Y., Nakamura, H., Yoshida, K., Enomoto, H., Uyama, H., Hirotani, T., Funamoto, M., Ito, H., Everett, A.D., Hada, T., Kawase, I. Cancer Sci. (2003)
- Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor. Klagsbrun, M., Sasse, J., Sullivan, R., Smith, J.A. Proc. Natl. Acad. Sci. U.S.A. (1986)
- Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma. Yoshida, K., Tomita, Y., Okuda, Y., Yamamoto, S., Enomoto, H., Uyama, H., Ito, H., Hoshida, Y., Aozasa, K., Nagano, H., Sakon, M., Kawase, I., Monden, M., Nakamura, H. Ann. Surg. Oncol. (2006)